Accendra Health (ACH)
Provides home medical equipment and supplies through Apria and Byram.
$0.7633
vs last close−0.09 (−10.20%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,592 | 2,656 | 2,613 | 660 | 687 | 2,696 | 2,632 | 682 | 697 | 709 | 628 | 613 |
| Cost of revenue | 2,053 | 2,086 | 2,077 | 344 | 355 | 2,116 | 2,106 | 357 | 375 | 386 | 350 | 350 |
| Gross profit | 538 | 570 | 536 | 316 | 332 | 580 | 526 | 325 | 322 | 323 | 278 | 263 |
| 515 | 510 | 526 | 299 | 301 | 842 | 526 | 268 | 266 | 271 | 255 | 299 | |
| Research & development | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 453 | 457 | 478 | 270 | 272 | 493 | 462 | 268 | 266 | 271 | 255 | 244 | |
| Selling & marketing | 453 | −1,356 | 478 | 0 | 0 | 0 | 462 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 0 | 1,814 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other expenses | 62 | 39 | 48 | 29 | 28 | 349 | 64 | 0 | 0 | 0 | 0 | 55 |
| Operating income | 24 | 60 | 10 | 17 | 31 | −262 | 0 | 57 | 56 | 52 | 23 | −35 |
| −35 | −39 | −37 | −26 | −30 | −38 | −35 | −142 | −60 | −60 | −39 | −52 | |
| Interest expense | 38 | 37 | 36 | 36 | 37 | 36 | 34 | 26 | 29 | 28 | 32 | 35 |
| Other non-operating income | −3 | −28 | 1 | 1 | 1 | 2 | 1 | 116 | 31 | 32 | 7 | 18 |
| Income before tax | −11 | 21 | −27 | −9 | 1 | −300 | −35 | −85 | −4 | −8 | −16 | −88 |
| Income tax expense | −5 | 3 | −5 | −3 | 0 | −4 | −10 | −1 | 2 | 1 | −10 | 1 |
| Net income from continuing operations | −6 | 18 | −22 | −7 | 1 | −296 | −25 | −84 | −6 | −9 | −6 | −89 |
| Discontinued operations | 0 | 0 | 0 | −25 | −14 | 0 | 0 | −785 | −145 | −47 | 0 | 0 |
| Net income | −6 | 18 | −22 | −32 | −13 | −296 | −25 | −869 | −150 | −56 | −6 | −89 |
| EPS, basic | −$0.08 | $0.23 | −$0.29 | −$0.42 | −$0.17 | −$3.84 | −$0.32 | −$11.30 | −$1.94 | −$0.73 | −$0.08 | −$1.16 |
| EPS, diluted | −$0.08 | $0.23 | −$0.29 | −$0.42 | −$0.17 | −$3.84 | −$0.32 | −$11.30 | −$1.94 | −$0.73 | −$0.08 | −$1.16 |
| Weighted average shares, basic | 76 | 76 | 76 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 |
| Weighted average shares, diluted | 76 | 78 | 76 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 |
| EBITDA | 101 | 158 | 83 | 80 | 92 | −199 | 60 | 19 | 89 | 50 | 78 | 13 |
| Depreciation & amortization | 74 | 71 | 74 | 64 | 62 | 65 | 61 | 78 | 64 | 30 | 62 | 66 |
| EBIT | 27 | 88 | 9 | 16 | 30 | −264 | −1 | −59 | 25 | 20 | 16 | −53 |
